Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION

Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC") has today, 17 September 2026, bought 2,500,000 shares in HBC in an off-market transaction at an average price of NOK 1.13 per share. 

After the transaction, Mr. Baldegger holds 8,824,899 shares in HBC, equal to approximately 1.86 % of the total outstanding A-shares with voting rights. 

For further information, contact: 
Jon Olav Ødegård, CEO of Hofseth BioCare ASA 
Phone: +47 936 32 966 E-mail: [email protected]

This information is subject to the disclosure requirements in the Market Abuse Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Attachment

• KRT-1500 2026-09-17 Christoph Baldegger

You May Also Be Interested In

• Tampa Bay Wave Portfolio Companies Surpass $2 Billion in Capital Raised
• Hemisphere Energy Provides Operations Update
• BioConsortia Appoints Matthew Mouw as Vice President of Business Development